expert perspectives

Expert Perspectives in HR+ HER2- Breast Cancer to Cover Key Topics in HR+ HER2- Breast Cancer Treatment

by Tom Iarocci, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. On behalf of Expert Perspectives in Medicine Editor-in-Chief Tom Iarocci, MD, we are delighted to introduce the community-selected topics for Expert Perspectives in HR+ HER2- Breast Cancer. We hope you will find these topics of value in your clinical practice.




VIEW THE TOPICS 

Expert Roundtables 

  • Advances in the Treatment of HR+/HER2- Breast Cancer
  • Extending Overall Survival in HR+/HER2- Advanced Breast Cancer 
  • HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies 
  • HR+/HER2- Breast Cancer: Approach to Metastatic Disease
  • Preserving Health-Related Quality of Life in Patients With Advanced Breast Cancer
  • The Role of Biomarkers in Treatment Selection for Patients With HR+ Metastatic Breast Cancer


Clinical Topic Updates 

  • Biomarkers of Response in HR+/HER2- Breast Cancer 
  • Conference Roundup: Locally Advanced HR+/HER2- Breast Cancer 
  • The Importance of Next-Generation Sequencing in Guiding Therapy Selection
  • Mechanisms of Action of CDK4/6 Inhibition in Breast Cancer: Recent Insights
  • Second-line Treatment for Advanced/Metastatic HR+/HER2- Breast Cancer
  • The Role of Gene Expression Profiles in Breast Cancer Treatment


Patient Care Perspectives 

  • Breast Cancer Immuno-Oncology and the Effects of Treatments on the Immune Milieu 
  • Challenges in the Multidisciplinary Management of Breast Cancer
  • First-line Therapy for Advanced HR+/HER2- Breast Cancer
  • HR+/HER2- Breast Cancer: Approach to Progression During Aromatase Inhibitor Therapy
  • Novel Options for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
  • Premenopausal Women With Advanced HR+ Breast Cancer

More in HR-Positive HER2-Negative Breast Cancer

Thumb

HR-Positive HER2-Negative Breast Cancer

Biomarkers of Response in HR+ HER2- Breast Cancer

Clinical Topic Updates by Matthew P. Goetz, MD

Estrogen receptor (ER) expression remains the most important predictive biomarker of response to endocrine therapy in hormone receptor–positive (HR...READ MORE

Thumb

HR-Positive HER2-Negative Breast Cancer

The Role of Gene Expression Profiling in Breast Cancer Treatment Selection

Clinical Topic Updates by Matthew P. Goetz, MD

Gene expression profiling is an emerging tool to help guide treatment decisions in patients with breast cancer. In particular, it has been used to ...READ MORE

Thumb

HR-Positive HER2-Negative Breast Cancer

The Importance of Next-Generation Sequencing in Guiding Therapy Selection

Clinical Topic Updates by Matthew P. Goetz, MD

Our understanding of the genetic and molecular alterations associated with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2...READ MORE

More In Oncology

HER2-Positive Breast Cancer

Recent Developments in HER2-Targeted Therapy

Clinical Topic Updates by Ian Krop, MD, PhD

cGVHD

Prophylactic Strategies in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Expert Roundtables by Sergio A. Giralt, MD; John Koreth, MBBS, DPhil; and Robert S. Negrin, MD